1. | The plan is subject to ERISA therefore the Plan is filing Plan financial statements and schedules prepared in accordance with financial reporting requirements of ERISA. | |
2. | A written consent of the accountant. |
Page(s) | ||||
1 | ||||
Financial Statements |
||||
2 | ||||
3 | ||||
4-9 | ||||
Supplemental Schedule* |
||||
10 |
* | Note: Other schedules required by Section 2520.103-10 of the Department of Labors Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974 have been omitted because they are not applicable. |
(in thousands of dollars) | 2005 | 2004 | ||||||
Assets |
||||||||
Investments, at fair value |
||||||||
Common stocks |
$ | 14,608 | $ | 17,543 | ||||
Common/collective trust funds |
10,468 | 8,592 | ||||||
Mutual funds |
78,172 | 68,648 | ||||||
Loans to participants |
1,706 | 1,535 | ||||||
Total investments |
104,954 | 96,318 | ||||||
Cash equivalents |
259 | 450 | ||||||
Receivables |
||||||||
Accrued income |
168 | 173 | ||||||
Unsettled investment sales |
256 | 29 | ||||||
Total receivables |
424 | 202 | ||||||
Total assets |
105,637 | 96,970 | ||||||
Liabilities |
||||||||
Payables |
||||||||
Unsettled investment purchases |
25 | 8 | ||||||
Total liabilities |
25 | 8 | ||||||
Net assets available for benefits |
$ | 105,612 | $ | 96,962 | ||||
2
(in thousands of dollars) | 2005 | |||
Additions to net assets attributed to: |
||||
Interest and dividend income |
$ | 1,573 | ||
Net appreciation in fair value of investments |
5,591 | |||
Contributions |
||||
Participants |
11,668 | |||
Employer |
3,734 | |||
Rollovers from other plans |
569 | |||
Total contributions |
15,971 | |||
Total additions |
23,135 | |||
Deductions from net assets attributed to: |
||||
Benefits paid to participants |
13,687 | |||
In-kind distributions to participants |
783 | |||
Administrative expenses |
15 | |||
Total deductions |
14,485 | |||
Net increase |
8,650 | |||
Net assets available for benefits: |
||||
Beginning of year |
96,962 | |||
End of year |
$ | 105,612 | ||
3
1. | Description of the Plan | |
The following description of the Merial 401(k) Savings Plan (the Plan) is provided for general information purposes. Participants of the Plan should refer to the Plan document for a more complete description of the Plans provisions. | ||
General The Plan is a defined contribution plan, which is subject to the provisions of the Employee Retirement Income Security Act of 1974 (ERISA). The Plan covers all full-time and part-time employees of Merial Limited and Merial Select (the Company), who have enrolled as participants. The Plan was originally adopted effective January 1, 1989. |
||
Eligibility An employee is eligible to participate in the Plan as soon as administratively feasible, following the date on which he or she performs his or her first hour of service with the employer and executes a salary reduction agreement. Employees who are part of a collective bargaining agreement or are not United States citizens are not eligible to participate in the Plan. |
||
Participant Contributions Under the provision of the Plan, allowable contributions are outlined as follows: |
||
Salary Reduction Agreement: Participants may elect to enter a salary reduction agreement of up to 15% of the participants compensation. These amounts are credited to the participants account as pre-tax contributions. The maximum amount of compensation that a participant may elect to defer for the year ended December 31, 2005 was $14,000. | ||
Voluntary Contributions: In addition to pre-tax contributions made through the salary reduction agreement, a participant may make voluntary non-deductible contributions to their account in an amount up to 15% of their compensation; provided, however, that the total percentage of voluntary contributions and salary reduction contributions do not exceed 15% of the participants compensation for each payroll period within a plan year. | ||
Catch up Contributions: Participants who have attained age 50 before the end of the Plan year are eligible to make catch-up contributions. The maximum catch-up contribution available to participants for 2005 was $4,000. | ||
Employer Contributions | ||
The employer makes matching contributions to the participants account equal to 100% of the participants salary reduction contributions and voluntary contributions up to 3% of the participants compensation and 50% of a participants salary reduction contributions between 3% and 6% of the participants compensation. | ||
Effective January 1, 2005, the Plan was amended such that compensation shall include commissions received by the participant from the employer. |
4
Participant Accounts Each participants account is credited with the participants contribution and allocations of (a) the Companys contribution and (b) Plan earnings, and charged with an allocation of administrative expenses. Allocations are based on participant earnings or account balances, as defined. The benefit to which a participant is entitled is the benefit that can be provided from the participants vested account. |
||
Vesting Participants are vested immediately in their contributions and employer contributions plus actual earnings thereon. |
||
Investments The trustee of the Plan is Wells Fargo Bank Minnesota, N.A. (hereafter referred to as Trustee). It is the duty of the Trustee to acquire and dispose of the Plans assets and to perform such other services as the Trustee shall deem necessary or desirable in connection with the management of the Plans investment holdings. |
||
Withdrawals Participants may elect to withdraw any portion of their employee contribution accounts, employer match account, or rollover account for any reason after attainment of age 59 1/2. Participants under age of 59 1/2 that have a specified financial hardship may withdraw all or any portion of their salary reduction contributions. |
||
Participant Loans Participants have the ability to borrow against their vested account balance in the Plan. Participants may borrow 50% of their vested account balance, up to $50,000 in any twelve-month period. The loans are collateralized by the balance in the participants account and bear interest at rates that range from 4.75% to 9.50%, which are commensurate with local prevailing rates charged by lenders for similar loans. |
||
Each loan is collateralized by the assignment of the borrowers entire right, title and interest in his/her participant account. Loans may be repaid over one to five years or thirty years, based on the type of loans, as defined, and the entire unpaid principal balance of the loan is due either upon the participants termination or a default in payment of either principal or interest. Repayment of a loan shall be made through payroll deduction at least quarterly. | ||
Payment of Benefits When a participant terminates service with the Company or reaches his or her normal retirement date, the balance of the account is payable to the participant. For participants with account balances in excess of $5,000, an election is available to defer the distribution until the participants normal retirement date. The normal retirement date is the date the participant reaches age 65. Participants may elect to receive the distribution as either a lump sum payment in cash or annual installment payments in cash over a period not to exceed ten years. |
||
2. | Summary of Significant Accounting Policies | |
Basis of Accounting The financial statements of the Plan are prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America. |
5
Use of Estimates The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes, herein, and disclosures of contingent assets and liabilities. Actual results may differ from these estimates. |
||
Investment Valuation Common stocks are valued on the basis of the closing price per share on December 31, 2005 and 2004 as reported on the New York Stock Exchange or, if no sales were made on that date, at the closing price on the next preceding day on which sales were made. Investments in mutual funds and common/collective trust funds are valued at the last reported net asset value on each valuation date. Loans to participants are carried at their outstanding balance, which approximates fair value. |
||
Investment Transactions and Income Investment transactions are recorded on a trade-date basis. Dividend income is recorded on the ex-dividend date. Interest is recognized on an accrual basis. The net appreciation or depreciation in market value of investments consists of realized gains and losses and changes in unrealized appreciation or depreciation of these investments during the year. Realized gains and losses on investments are determined on the basis of average cost. Unrealized gains or losses on investments are based on changes in the market values or fair values of such investments. |
||
Payment of Benefits Distributions to participants are recorded when payment is made. In-service withdrawals will generally be made in cash. Participants have the option of requesting any portion of an in-service withdrawal that is invested in Merck and Company, Inc. (Merck) or Avantis ADRs in shares rather than cash (in kind distribution). In-kind distributions are recorded based on the market value of the shares at the date of distribution. |
||
Cash and cash equivalents The Plan considers all highly liquid investments with a maturity of three months or less, when acquired, to be cash equivalents. |
||
Administrative Expenses Administrative expenses may be paid by the Company. During 2005, expenses were paid by the Company with the exception of loan application and annual maintenance fees, which are paid directly out of the Plans funds and charged to the participants accounts. The loan application and annual loan maintenance fees are paid by specific participants with outstanding loans. Administrative expenses for 2005 were $15,000. |
||
Reclassification Certain 2004 balances have been reclassified to conform to the 2005 financial statement presentation. |
6
3. | Investments | |
Investments, at fair value are as follows: |
(in thousands of dollars) | 2005 | 2004 | ||||||
Common stocks: |
||||||||
Merck and Company, Inc. |
$ | 12,346 | * | $ | 13,608 | * | ||
Medco Health Solutions, Inc. |
| 1,556 | ||||||
Aventis ADR** |
| 654 | ||||||
Sanofi-Aventis ADR** |
2,262 | 1,725 | ||||||
Total Common stocks |
14,608 | 17,543 | ||||||
Common/Collective Trust Fund |
||||||||
Wells Fargo Collective Stable Return Fund |
10,468 | * | 8,592 | * | ||||
Total Common/Collective Trust Fund |
10,468 | 8,592 | ||||||
Mutual Funds |
||||||||
Wells Fargo Advantage Large Company Growth Fund |
11,151 | * | 11,503 | * | ||||
Allianze Small Cap Value Fund |
14,467 | * | 13,296 | * | ||||
AIM Basic Value Fund |
11,351 | * | 11,501 | * | ||||
Fidelity Investment Diversified International Fund |
10,055 | * | 7,425 | * | ||||
Artisan Mid Cap Fund |
6,750 | * | 6,390 | * | ||||
Pimco Total Return Fund |
5,109 | 4,483 | ||||||
Wells Fargo Advantage Aggressive Allocation Fund |
3,617 | 2,934 | ||||||
Wells Fargo Advantage Growth Balanced Fund |
3,273 | 2,633 | ||||||
Wells Fargo Advantage Moderate Balance Fund |
2,150 | 1,900 | ||||||
Wells Fargo Advantage Conservative Fund |
1,948 | 1,566 | ||||||
Wells Fargo Advantage Index Fund |
1,750 | 1,351 | ||||||
Neuberger Berman Fasciano |
1,368 | 948 | ||||||
Lord Abbett Mid Cap Value |
5,183 | 2,718 | ||||||
Total Mutual Funds |
78,172 | 68,648 | ||||||
Loans to participants |
1,706 | 1,535 | ||||||
Total investments |
$ | 104,954 | $ | 96,318 | ||||
* | These investments represent 5% or more of the Plans net assets as of the end of the plan year. | |
** | ADR American Depository Receipts |
7
1. | During the year ended December 31, 2005, the Plans investments (including gains and losses on investments bought and sold, as well as held during the year) appreciated/(depreciated) in value by $5,591,000 as follows: |
(in thousands of dollars) | 2005 | |||
Type of Investments |
||||
Common stocks |
$ | 370 | ||
Common/collective trust fund |
360 | |||
Mutual Funds |
4,861 | |||
$ | 5,591 | |||
4. | Plan Termination | |
Although it has not expressed any intent to do so, the Company reserves the right under the Plan to terminate the Plan, in whole or in part, at any time subject to the provisions of ERISA. Whole or partial termination of the Plan shall result in full and immediate vesting of each affected participant in their entire account balance and there shall not thereafter be any forfeitures with respect to any such affected participant for any reason. | ||
5. | Parties-In-Interest | |
Certain plan investments are shares of mutual funds managed by the Trustee as defined by the Plan, and therefore these transactions qualify as party-in-interest transactions. Fees paid by the Plan for administrative expenses amounted to $15,000 for the year ended December 31, 2005. | ||
The Company is jointly (50/50) owned by Merck and Sanofi-Aventis (collectively the Parents). The Plan allows for investment in shares of the Parents. | ||
At December 31, 2005, the Plan held investments of $12,346,000 or 388,121 shares of Merck common stock. | ||
During 2003, Merck spun off its Medco Health Solutions, Inc. (Prescription Benefit Manager) (Medco) division into a separate company. As a result of this divestiture, participants in the Merck Stock plan received a pro-rata amount of Medco stock based on their Merck ownership. This Medco stock was established as a wasting fund within the Plan from which participants could sell shares but could not purchase additional shares. The Medco fund was liquidated in September, 2005. As of December 31, 2005, the Plan held no shares of Medco common stock. | ||
During the 2004 plan year, Aventis was purchased by a competitor, Sanofi Synthelabo, forming a new company known as Sanofi-Aventis. As part of the purchase, Sanofi Synthelabo tendered an offer to Aventis ADR (American Depository Receipts) Plan participants to purchase their stock in exchange for Sanofi Synthelabo stock and cash. This transaction resulted in a residual amount of Aventis ADRs (participants who did not exchange their Aventis ADRs) and Sanofi-Synthelabo ADRs (participants who exchanged their Aventis ADRs). The Aventis ADR Fund was frozen upon the sale of Aventis. An SEC Form S-8 is in preparation which will establish a Sanofi-Aventis ADR Fund, which will be opened to plan participants when approved. | ||
As of December 31, 2005 the Plan held investments of $2,262,000 or 51,512 shares of Sanofi- |
8
Aventis ADRs. | ||
6. | Tax Status | |
The Plan obtained its latest determination letter on September 7, 2001, in which the Internal Revenue Service stated that the Plan, as then designed, was in compliance with the applicable requirements of the Code. The Plan has been amended since its latest determination letter. The Plan administrator believes that the Plan is currently designed and being operated in compliance with the applicable requirements of the Code. Therefore, the Plan administrator believes that the Plan was qualified and the related trust was tax exempt as of the financial statement date. | ||
7. | Risks and Uncertainties | |
The Plan invests in various investment securities. Investment securities are exposed to various risks such as interest rate, market, and credit risks. Due to the level of risk associated with certain investment securities, it is at least reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect participants account balances and amounts reported in the statement of net assets available for benefits. |
9
(b) Identity of issue | (c) Description of investments, including | |||||||
borrower, lessor, or | maturity date, rate of interest, collateral, | (e) Current | ||||||
(a) | similar party | par or maturity value | value | |||||
* |
Merck and Company, Inc. | Common Stock, 388,121 shares | $ | 12,346 | ||||
* |
Sanofi-Aventis | 51,512 American depository receipts | 2,262 | |||||
Total - Common Stock | 14,608 | |||||||
* |
Wells Fargo Collective Stable Return Fund | Common Collective Fund, 275,477 units | 10,468 | |||||
Total - Common Collective Trust Fund | 10,468 | |||||||
* |
Wells Fargo Large Company Growth Fund | Mutual Fund, 226,471 units | 11,151 | |||||
Allianz Small Cap Value Fund | Mutual Fund, 500,256 units | 14,467 | ||||||
AIM Basic Value Fund | Mutual Fund, 331,719 units | 11,351 | ||||||
Fidelity Investments Diversified International Fund | Mutual Fund, 476,534 units | 10,055 | ||||||
Artisan Mid Cap Fund | Mutual Fund, 218,292 units | 6,750 | ||||||
Pimco Total Return Fund | Mutual Fund, 486,592 units | 5,109 | ||||||
* |
Wells Fargo Advantage Aggressive Allocation Fund | Mutual Fund, 252,379 units | 3,617 | |||||
* |
Wells Fargo Advantage Growth Balanced Fund | Mutual Fund, 112,358 units | 3,273 | |||||
* |
Wells Fargo Advantage Moderate Balance Fund | Mutual Fund, 102,358 units | 2,150 | |||||
* |
Wells Fargo Advantage Conservative Allocation Fund | Mutual Fund, 102,701 units | 1,948 | |||||
* |
Wells Fargo Index Fund | Mutual Fund, 34,948 units | 1,750 | |||||
Neuberger Berman Fascino Fund | Mutual Fund, 32,270 units | 1,368 | ||||||
Lord Abbett Mid Cap Value Fund | Mutual Fund, 231,290 units | 5,183 | ||||||
Total - Mutual Fund | 78,172 | |||||||
* |
Participants' loans | Loans to participants at interest rates, | ||||||
ranging from 4.75% to 9.50% with | ||||||||
maturities through 2030 | 1,706 | |||||||
$ | 104,954 | |||||||
* | Denotes party-in-interest to the Plan. |
10
SIGNATURES | ||||||||
EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM |
Merial 401(k) Savings Plan | ||||||||
Date |
June 29, 2006 | /s/ Jean Mauldin | ||||||
Chief Financial Officer |